The results demonstrated that 123I-VEGF uptake was highly specific to WHO grade IV gliomas: 14 of 16 patients with grade IV tumors showed significant uptake at 18 h, whereas no increased uptake was observed in patients with grade II or III tumors. Here, VEGFA is linked to glioma.